Pharmaceutical Technologies
Pharmaceutical Technologies
Featured Story
UPM Raflatac and Corning Conduct Collaborative Study to Help Advance Sustainability in Pharma Packaging
UPM Raflatac and Corning Conduct Collaborative Study to Help Advance Sustainability in Pharma Packaging
UPM Raflatac, a global supplier of self-adhesive paper and film products, and Corning Pharmaceutical Technologies, a division of Corning Incorporated, one of the world’s leading innovators in materials science, have today announced the results of a collaborative study. The results show that a combination of the two companies’ products performs well in a variety of challenging drug product storage conditions and offers significant sustainability benefits for pharmaceutical industry innovators.
Corning Pharmaceutical Technologies
Corning Pharmaceutical Technologies
Learn MoreU.S. Departments of Defense, Health & Human Services select Corning Valor® Glass packaging to accelerate delivery of COVID-19 vaccines
U.S. Departments of Defense, Health & Human Services select Corning Valor® Glass packaging to accelerate delivery of COVID-19 vaccines
The Race to Make Vials for Coronavirus Vaccines
The Race to Make Vials for Coronavirus Vaccines
Read MoreA Corning factory in upstate New York is running around the clock to help meet the urgent demand.
Photography by Christopher Payne for The New Yorker
A Corning factory in upstate New York is running around the clock to help meet the urgent demand.
Photography by Christopher Payne for The New Yorker
Working Together to Distribute a Vaccine
Working Together to Distribute a Vaccine
Watch NowAs experts developed a vaccine for COVID-19, many began to wonder how the vaccine will actually be transported. With the help of companies like Corning, Inc., Natuzzi Ice and Thermo King, the vaccine will be safely distributed around the country.
As experts developed a vaccine for COVID-19, many began to wonder how the vaccine will actually be transported. With the help of companies like Corning, Inc., Natuzzi Ice and Thermo King, the vaccine will be safely distributed around the country.
Inside the race to make vials for the Coronavirus Vaccine in upstate New York
Inside the race to make vials for the Coronavirus Vaccine in upstate New York
Watch NowNBC’s Gary Grumbach gets an inside look at the operation going on inside a glass company in upstate New York, as employees work around the clock to ensure they are producing enough glass vials for the Coronavirus vaccine. Corning Inc. is one of two private companies selected by “Operation Warp Speed” to create the vials, which have distinct properties. It was allocated $204 million to increase production, in hopes of manufacturing 164 million vials a year.
NBC’s Gary Grumbach gets an inside look at the operation going on inside a glass company in upstate New York, as employees work around the clock to ensure they are producing enough glass vials for the Coronavirus vaccine. Corning Inc. is one of two private companies selected by “Operation Warp Speed” to create the vials, which have distinct properties. It was allocated $204 million to increase production, in hopes of manufacturing 164 million vials a year.
Covid-19 Vaccines Could Depend on the Strength of This Vial
Covid-19 Vaccines Could Depend on the Strength of This Vial
Read MoreDrugmakers and health authorities are counting on Corning’s new medical glass container, named Valor, to protect Covid-19 vaccines better than conventional ones, especially during initial months when supplies will be limited and little can afford to be lost.
Drugmakers and health authorities are counting on Corning’s new medical glass container, named Valor, to protect Covid-19 vaccines better than conventional ones, especially during initial months when supplies will be limited and little can afford to be lost.
.png)
.png)
.png)
Valor® Glass In the News
Corning to Create 1,000 new US Jobs
Corning's CEO Discusses Pharma Initative with CNBC
CNBC's "Closing Bell" interviewed Corning CEO and Chairman, Wendell Weeks on the newly announced collaboration with Merck and Pfizer to create new pharmaceutical glass packaging, and Corning's investment of $500M to create U.S.-based jobs.
CNBC's "Closing Bell" interviewed Corning CEO and Chairman, Wendell Weeks on the newly announced collaboration with Merck and Pfizer to create new pharmaceutical glass packaging, and Corning's investment of $500M to create U.S.-based jobs.
Read More
Corning Donates Safety Supplies to Inspira Health Foundation
Corning Donates Safety Supplies to Inspira Health Foundation
Corning recently donated surgical masks to Inspira Health Foundation in Vineland, N.J. This foundation is overseeing the distribution of all medical supplies to its hospital facilities supporting the urgent needs of frontline medical staff combating the COVID-19 crisis.
Corning recently donated surgical masks to Inspira Health Foundation in Vineland, N.J. This foundation is overseeing the distribution of all medical supplies to its hospital facilities supporting the urgent needs of frontline medical staff combating the COVID-19 crisis.
President Trump tests Valor Glass
CNN Reports on "Made in America" Week, Corning Announces Valor Glass
CNN provides coverage of the White House event during "Made in America" Week, where Corning annouced a collaboration with Merck and Pfizer to develop Corning Valor® Glass.
CNN provides coverage of the White House event during "Made in America" Week, where Corning annouced a collaboration with Merck and Pfizer to develop Corning Valor® Glass.
Read More
Fortune Highlights Collaboration
Fortune Highlights Corning's Announcement with Merck, Pfizer
Fortune provides coverage on Corning's recent announcement at the White House to invest $500M and create 1,000 new U.S. jobs during "Made in America" Week.
Fortune provides coverage on Corning's recent announcement at the White House to invest $500M and create 1,000 new U.S. jobs during "Made in America" Week.
Read MorePharmaceutical Technologies Headlines
Corning’s New Viridian® Vials Reduce Waste and Carbon Emissions in the Pharmaceutical Supply Chain
Corning’s New Viridian® Vials Reduce Waste and Carbon Emissions in the Pharmaceutical Supply Chain
press-release, 13-Jul-2023
The vial technology will help drug manufacturers meet their sustainability goals while enabling faster, safer filling-line operations
The vial technology will help drug manufacturers meet their sustainability goals while enabling faster, safer filling-line operations
Corning and SGD Pharma Announce Joint Venture to Open New Glass Tubing Facility and Expand Access to Corning® Velocity® Vial Technology in India
Corning and SGD Pharma Announce Joint Venture to Open New Glass Tubing Facility and Expand Access to Corning® Velocity® Vial Technology in India
press-release, 08-Jun-2023
The collaboration will enable faster, more efficient delivery of vital medicines and help support India’s growing pharmaceutical industry
Read MoreCorning Introduces the Velocity® Vial Technology Platform, Expanding Industry Partnerships
Corning Introduces the Velocity® Vial Technology Platform, Expanding Industry Partnerships
article, 23-Mar-2023
Through the platform, Corning will expand its manufacturing footprint, localize its supply chains, and enable the purchase of Velocity Vials through a network of selling partners.
Read More